As the world’s largest biotech company, Roche is focused on advancing science to improve people’s lives. Our personalized healthcare strategy is designed to fit the right treatment to each patient and includes an expanding portfolio of digital diagnostics solutions. The recently launched NAVIFY clinical decision support platform helps multidisciplinary care teams navigate increasingly complex medical information and empowers them with holistic and actionable data. The first commercially available product in the portfolio is NAVIFY Tumor Board, a cloud-based software solution that changes the way oncology care teams prepare for, conduct and document clinical treatment decisions. In addition to standardizing and streamlining the tumor board workflow, the software offers additional clinical decision support applications that match patients to relevant clinical trials and published studies enabling clinicians to make faster, more informed treatment decisions.